UroGen Pharma Ltd
URGN
27.65
-4.08
-12.86%
UroGen Pharma Ltd
US · URGN
#2773 by market cap
Listed 2017
27.65
-4.08
-12.86%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About UroGen Pharma Ltd
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
- Founded
- 2004
- CEO
- Ms. Elizabeth Barrett
- Employees
- 291
- Headquarters
- Princeton, New Jersey, United States of America
- Fiscal year end
- 12-31
- Website
- urogen.com
Company profile
- Exchange
- US
- Symbol
- URGN
- Market-cap rank
- #2773
- Listing date
- 2017-05-04
- Market cap
- 1.36B
- Float cap
- 1.20B
- Shares out
- 49.05M
- Float shares
- 43.57M
Sectors & themes
Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.
UroGen Pharma Ltd discussion 0 comments